Status:
RECRUITING
Rare Subtypes of Gastrointestinal Cancers
Lead Sponsor:
Aarhus University Hospital
Conditions:
Cancer of Gastrointestinal Tract
Eligibility:
All Genders
18+ years
Brief Summary
A single-arm prospective observational translational study of biomarkers in patients receiving targeted treatment for rare subtypes of cancer of the Gastrointestinal Tract.
Detailed Description
In this study, the investigators seek to investigate biological aspects in patients receiving targeted treatment for rare subtypes of cancer of the Gastrointestinal. The targeted treatment will be gi...
Eligibility Criteria
Inclusion
- Diagnosis of a rare subtype of GI cancer including BRAF V600E mutation, MSI-H, HER2 and others
- Diagnosis of cancer of the gastrointestinal tract may be made by histo- or cyto-pathology, or by clinical and imaging criteria
- Planned for targeted treatment
- Age 18 years or older
- Able to understand written information
- Consent to samples for translational research
Exclusion
- Conditions precluding translational blood sampling
- Another concomitant cancer
Key Trial Info
Start Date :
August 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04838327
Start Date
August 16 2021
End Date
April 1 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Aarhus University Hospital
Aarhus N, Denmark, 8200